Form 4: Artivion SVP Sells Shares for Tax Obligations

Artivion's SVP, Clinical & MD Affair, Marshall S. Stanton, sold shares to cover tax withholding obligations related to vested equity awards.

Summary

• Marshall S. Stanton, SVP, Clinical & MD Affair at Artivion, Inc. (AORT), reported two non-discretionary sales of common stock.
• On February 23, 2026, 2,423 shares were sold at a price of $37.588 per share.
• On February 24, 2026, an additional 1,259 shares were sold at a price of $35.693 per share.
• These sales were executed to satisfy tax withholding obligations upon the vesting of performance stock units and restricted stock units, funded by a 'sell to cover' transaction.
• Following these transactions, Marshall S. Stanton beneficially owns 41,921 shares of Artivion common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine, non-discretionary transaction to cover tax obligations, which typically has a neutral impact on market sentiment as it does not reflect a change in the insider's investment conviction.

Negatives

• A reduction in the reporting person's direct beneficial ownership of common stock by a total of 3,682 shares.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.

Industry Context

StockSavvy.ai notes that 'sell to cover' transactions, where executives sell a portion of their vested equity awards to satisfy tax obligations, are a common and routine practice across industries. These transactions are generally non-discretionary and are typically not interpreted as a signal of management's sentiment regarding the company's future prospects, unlike open market discretionary sales.

Stakeholder Impact

• Shareholders: The transactions result in a minor reduction in insider ownership, but given their non-discretionary nature for tax purposes, the impact on shareholder confidence is generally neutral.

Key Dates

Recommendation

The reported transactions are non-discretionary sales to cover tax withholding obligations upon the vesting of equity awards. Such 'sell to cover' transactions are common and do not typically signal a change in management's outlook or a fundamental shift in the company's prospects, thus warranting a neutral 'hold' recommendation based solely on this filing.

Keywords

ARTIVION, AORT, SEC Form 4, Insider Transaction, Stock Sale, Equity Compensation, Tax Withholding, Marshall S. Stanton, Sell to Cover